2 reports

IS DEVELOPING CELLULAR IMMUNOTHERAPY.

  • Immunotherapy
  • Neurological Disorder
  • Pathology
  • Therapy
  • Anavex Life Sciences Corp.

THE DRUG CANDIDATE IS BASED ON COMPOSITE HUMAN ANTIBODY TECHNOLOGY.

  • Immunotherapy
  • Neurological Disorder
  • Pathology
  • Therapy
  • Anavex Life Sciences Corp.